Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review

被引:79
作者
Agarwal, Nikhil [1 ]
Ollington, Kevin [1 ]
Kaneshiro, Marc [1 ]
Frenck, Robert [2 ]
Melmed, Gil Y. [1 ]
机构
[1] Cedars Sinai Med Ctr, Dept Med, Div Gastroenterol, Los Angeles, CA 90048 USA
[2] Cincinnati Childrens Hosp, Dept Pediat, Cincinnati, OH USA
关键词
Vaccines; Influenza vaccines; Pneumococcal vaccines; Immunosuppressive medications; Tumor necrosis alpha; Solid organ transplant; Rheumatoid; Inflammatory bowel disease; Crohn's; Ulcerative colitis; HUMORAL IMMUNE-RESPONSE; RHEUMATOID-ARTHRITIS; INFLUENZA VACCINATION; TNF; RECOMMENDATIONS; METHOTREXATE; THERAPY;
D O I
10.1016/j.vaccine.2011.11.109
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Background: Long-term immunosuppressive medications are being used more commonly for a variety of medical conditions, including immune-mediated diseases and organ transplantation. While these medications are often necessary, they are associated with an increased risk of serious infections. Vaccination may be a way to prevent a variety of infections but vaccine responses among patients receiving immunosuppressive therapies have been variable. Purpose: To systematically review the literature describing immune responses among patients on immunosuppressive therapies to vaccinations including influenza, pneumococcal, meningococcal, hepatitis A and B, tetanus toxoid, pertussis, varicella, and zoster. Data sources: English language citations in the MEDLINE and EMBASE databases from 1985 to 2010. Study selection: Two reviewers independently screened titles and abstracts to identify prospective, controlled studies reporting pre- and post-vaccination titers of recommended vaccines in patients receiving long-term immunosuppressive therapies for full-text review. Data extraction: Three reviewers independently assessed study characteristics including treatment regimens and pre- and post-vaccination titers. Data synthesis: Of the 972 identified titles, fifteen met inclusion criteria. Ten studies assessed the effects of immunosuppressive medications on responses to influenza vaccine, four studies investigated responses following pneumococcal vaccination, and one study assessed both influenza and pneumococcal vaccination. Five of the studies that evaluated influenza vaccination showed partially diminished responses among individuals receiving immunosuppressive therapies, while one of the pneumococcal vaccine studies showed significantly decreased responses following vaccination. Patients treated with more than one immunosuppressive medication were the least likely to respond to vaccination. Limitations: The heterogeneity of reported outcomes limits generalizeability. Conclusions: Immunosuppressive therapy, particularly combination regimens, may blunt response to influenza and pneumococcal vaccinations. To ensure the best chance of response, immunizations should be administered prior to initiation of immunosuppressive medications whenever possible. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1413 / 1424
页数:12
相关论文
共 24 条
[1]
[Anonymous], 1993, MMWR Recomm Rep, V42, P1
[2]
Baghai M, 2001, MAYO CLIN PROC, V76, P653
[3]
The immunogenicity of influenza virus vaccine in solid organ transplant recipients [J].
Blumberg, EA ;
Albano, C ;
Pruett, T ;
Isaacs, R ;
Fitzpatrick, J ;
Bergin, J ;
Crump, C ;
Hayden, FG .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (02) :295-302
[4]
Vaccinations for adult solid-organ transplant recipients: Current recommendations and protocols [J].
Duchini, A ;
Goss, JA ;
Karpen, S ;
Pockros, PJ .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (03) :357-+
[5]
The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis [J].
Elkayam, O ;
Caspi, D ;
Reitblatt, T ;
Charboneau, D ;
Rubins, JB .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 33 (04) :283-288
[6]
Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients:: need for primary prophylaxis [J].
Esteve, M ;
Saro, C ;
González-Huix, F ;
Suarez, F ;
Forné, M ;
Viver, JM .
GUT, 2004, 53 (09) :1363-1365
[7]
Vaccination against influenza in rheumatoid arthritis:: the effect of disease modifying drugs, including TNFα blockers [J].
Fomin, I ;
Caspi, D ;
Levy, V ;
Varsano, N ;
Shalev, Y ;
Paran, D ;
Levartovsky, D ;
Litinsky, I ;
Kaufman, I ;
Wigler, I ;
Mendelson, E ;
Elkayam, O .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (02) :191-194
[8]
The effect of anti-tumour necrosis factor α treatment on the antibody response to influenza vaccination [J].
Gelinck, L. B. S. ;
van der Bijl, A. E. ;
Beyer, W. E. P. ;
Visser, L. G. ;
Huizinga, T. W. J. ;
van Hogezand, R. A. ;
Rimmelzwaan, G. F. ;
Kroon, F. P. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (05) :713-716
[9]
Kaine JL, 2007, J RHEUMATOL, V34, P272
[10]
Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients [J].
Kapetanovic, M. C. ;
Saxne, T. ;
Nilsson, J. -A. ;
Geborek, P. .
RHEUMATOLOGY, 2007, 46 (04) :608-611